Send feedback

NLRP14 p.Pro271Thr

c.811C>A · rs779403071 · VCV2387670

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely benign
0.2565 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0164%, mid)
Missense predictors
0/2 damaging
AlphaMissense, SaProt · REVEL indeterminate

Computational evidence

Protein change
AlphaMissense0.2565likely benign
REVEL0.424indeterminate
SaProtLLR -9.14tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL is indeterminate.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP 4.6GERP 1.9, phastCons 0.82
Regional constrainto/e 1.09unconstrained · MANE · 33 kb · p 0.0023 · regional, not allelic
Overall
CADD20.9PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0164% Middle Eastern · 1/6,084 alleles
Filtering AF 0.00757% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00706%
Overall 0.00774% 125/1,614,008 alleles · ultra-rare exomes 118/1,461,874 · genomes 7/152,134 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.027% 3,701
Middle Easterngrpmax 0.0164% 6,084
European (non-Finnish) 0.00898% 11,132
Remaining individualsnot grpmax-eligible 0.0064% 15,622
South Asian 0.00329% 30,361
Finnishnot grpmax-eligible 0.00312% 32,017
East Asian 0.00223% 44,892

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
NLRP14
Protein
p.Pro271Thr
Coding
c.811C>A
MANE Select
NM_176822
dbSNP
rs779403071
Type
single nucleotide variant
Location
chr11:7042837 (GRCh38)
Gene constraint
LOEUF 1.179 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 85.47 · 4 PDB
Residue 271
the nacht domain
Full NLRP14 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/nlrp14-p-pro271thr (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown